References
- 1. Jevsevar DS - Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 21(9):571–576
- 2. Balazs E - Viscosupplementation for osteoarthritis. from initial discovery to current status and results, Surg. Technol. Int. 12 (2004) 278–289.
- 3. Balazs E, Denlinger J - Viscosupplementation – a new concept in the treatment of osteoarthritis, J. Rheumatol. 20 (1993) 3–9.
- 4. Qvist P, Bay-Jensen A, Christiansen C et al. - The disease modifying osteoarthritis drug (DMOAD): is it in the horizon?, Pharmacol Res. 58 (2008) 1–7.10.1016/j.phrs.2008.06.001
- 5. Strauss E, Hart J, Miller M, et al. - Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions, Am. J. Sports Med. 37 (2009) 1636–1644.
- 6. Moreland L, Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action, Arthritis Res. Ther. 5 (2003) 54–67.10.1186/ar623
- 7. Vincent HK, Montero C, Conrad BP, et al. - “Functional Pain,” Functional Outcomes, and Quality of Life After Hyaluronic Acid Intra-articular Injection for Knee Osteoarthritis. PM R. 2013 Apr;5(4):310-8
- 8. Altman RD, Manjoo A, Fierlinger A, et al. - The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015; 16: 321
- 9. Smith MM, Russell AK, Schiavinato A, et al. - A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan. Journal of Inflammation (London, England). 2013;10:26.
- 10. Shimizu C. Kubo T, Hirasawa Y, et al. - Histomorphometric and biochemical effect of various hyaluronans on early osteoarthritis. J Rheumatol. 1998 Sep;25(9):1813-9.
- 11. Newberry SJ, Fitzgerald JD, Maglione MA, et al. - Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Jul.
- 12. Bagga H, Burkhardt D, Sambrook P, et al. - Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33(5):946-50
- 13. Skwara A, Peterlein CD, Tibesku CO, et al. - Changes of gait patterns and muscle activity after intraarticular treatment of patients with osteoarthritis of the knee: a prospective, randomised, doubleblind study. Knee. 2009 Dec;16(6):466-72.10.1016/j.knee.2009.03.003
- 14. Wang F, He X - Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: A meta-analysis. Exp Ther Med. 2015 Feb; 9(2): 493–500.
- 15. Creamer P - Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999 Sep;11(5):417-21.10.1097/00002281-199909000-00016
- 16. McAlindon TE - OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363-88
- 17. Carter GT, Duong V, Ho S, et al. - Side effects of commonly prescribed analgesic medications. Phys Med Rehabil Clin N Am. 2014 May;25(2):457-70.
- 18. Nuesch E, Rutjes AW, Husni E, Welch V, Juni P. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;(4):CD003115.
- 19. Rosemann T, Laux G, Szecsenyi J. Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J Orthop Surg Res. 2007 Jun 30;2:12.
- 20. Michael JW, Schlüter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010 Mar;107(9):152-62.
- 21. Scott J - Vertical or horizontal visual analogue scales. Ann Rheum Dis. 1979; 38:560. 4. McCormack HM, Horne DJL, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988; 18:1007–19.
- 22. Jensen MP - The measurement of clinical pain intensity: a comparison of six methods. Pain 1986; 27: 117–26.10.1016/0304-3959(86)90228-9
- 23. Burckhardt CS - Adult measures of pain: The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI). Arthritis Rheum 2003; 49: S96–104.
- 24. Romanian National Institute of Statistics - “Population by ethnicity 2011”
- 25. Smith MM, Russell AK, Schiavinato A, et al. - A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan. J Inflamm (Lond). 2013 Jul 27;10:26.
- 26. Finelli I, Chiessi E, Galesso D, et al. - A new viscosupplement based on partially hydrophobic hyaluronic acid: a comparative study. Biorheology. 2011;48(5):263-75.
- 27. Benazzo F, Perticarini L, Padolino A, et al. - A multi-centre, open label, long-term follow-up study to evaluate the benefits of a new viscoelastic hydrogel (Hymovis®) in the treatment of knee osteoarthritis. Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):959-68.
- 28. Conrozier T, Eymard F, Afif N, et al. - Safety and efficacy of intraarticular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial. Knee. 2016 Oct;23(5):842-8.
- 29. Askari A, Gholami T, NaghiZadeh MM, et al. - Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trail.
- 30. Ray TR - Using viscosupplementation to treat knee osteoarthritis. Phys Sportsmed. 2013 Nov;41(4):16-24.
- 31. Food and Drug Administration. Clinical Development Programs for Drugs, Devices, and Biological Products Intended for the Treatment of Osteoarthritis. Draft Guidance. Washington, DC: FDA; July 1999.